BABYF — Stock Film
STOCK FILMSCENE 1/11BABYF · $0.14
Stock Expert AI presents
BABYF
Else Nutrition Holdings Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Else Nutrition Holdings Inc. A quick introduction.

On the stock market since 2019, it operates in the everyday-essentials business. It has 32 employees. Now — the numbers.

on the stock market since 2019
32 employees
$2.3M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $2.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are growing — but slowly for a company this size.

Average growth of 6% a year over the last 4 years. Red columns mark years that ended in a loss.

$4.7M
2021
$8.5M
2022
$9.4M
2023
$8M
2024
$6M
2025
In the vault right now:
$0
DEBT: $1.9M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

Every quarter, analysts set a profit bar.
How many of the last 7 did the company clear?
4 / 7
EXPECTATIONS MET OR BEATEN
4
May 2024
Aug 2024
Nov 2024
Jun 2025
Jun 2025
Aug 2025
Nov 2025
4 TIMES IN THE LAST 7 QUARTERS
A mixed scorecard.
THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
Each sale is made at a loss3/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $6.0M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $8.9M against $6.0M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.14. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, BABYF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: BABYF is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film